382 related articles for article (PubMed ID: 25756795)
1. Positive pressure therapy for Ménière's disease or syndrome.
van Sonsbeek S; Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic gentamicin for Ménière's disease.
Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
[TBL] [Abstract][Full Text] [Related]
3. Positive pressure therapy for Ménière's disease.
Webster KE; George B; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015248. PubMed ID: 36815713
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Systemic pharmacological interventions for Ménière's disease.
Webster KE; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015171. PubMed ID: 36827524
[TBL] [Abstract][Full Text] [Related]
6. Intratympanic corticosteroids for Ménière's disease.
Webster KE; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Westerberg B; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015245. PubMed ID: 36847608
[TBL] [Abstract][Full Text] [Related]
7. Positive pressure therapy for Meniere's syndrome/disease with a Meniett device: a systematic review of randomised controlled trials.
Syed MI; Rutka JA; Hendry J; Browning GG
Clin Otolaryngol; 2015 Jun; 40(3):197-207. PubMed ID: 25346252
[TBL] [Abstract][Full Text] [Related]
8. Surgical interventions for Ménière's disease.
Lee A; Webster KE; George B; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015249. PubMed ID: 36825750
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle and dietary interventions for Ménière's disease.
Webster KE; George B; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Murdin L; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015244. PubMed ID: 36848645
[TBL] [Abstract][Full Text] [Related]
10. Surgery for Ménière's disease.
Pullens B; Verschuur HP; van Benthem PP
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD005395. PubMed ID: 23450562
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic gentamicin for Ménière's disease or syndrome.
Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
[TBL] [Abstract][Full Text] [Related]
12. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome.
Hussain K; Murdin L; Schilder AG
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012173. PubMed ID: 30596397
[TBL] [Abstract][Full Text] [Related]
13. Surgery for Ménière's disease.
Pullens B; Giard JL; Verschuur HP; van Benthem PP
Cochrane Database Syst Rev; 2010 Jan; (1):CD005395. PubMed ID: 20091573
[TBL] [Abstract][Full Text] [Related]
14. Betahistine in Ménière's Disease or Syndrome: A Systematic Review.
Van Esch B; van der Zaag-Loonen H; Bruintjes T; van Benthem PP
Audiol Neurootol; 2022; 27(1):1-33. PubMed ID: 34233329
[TBL] [Abstract][Full Text] [Related]
15. Systematic review and meta-analysis of Meniett therapy for Meniere's disease.
Ahsan SF; Standring R; Wang Y
Laryngoscope; 2015 Jan; 125(1):203-8. PubMed ID: 24913022
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic steroids for Ménière's disease or syndrome.
Phillips JS; Westerberg B
Cochrane Database Syst Rev; 2011 Jul; (7):CD008514. PubMed ID: 21735432
[TBL] [Abstract][Full Text] [Related]
17. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study.
Thomsen J; Sass K; Odkvist L; Arlinger S
Otol Neurotol; 2005 Jan; 26(1):68-73. PubMed ID: 15699722
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
Rajan GP; Din S; Atlas MD
J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops.
Shojaku H; Takakura H; Asai M; Fujisaka M; Ueda N; Do TA; Tsubota M; Watanabe Y
Acta Otolaryngol; 2021 Nov; 141(11):977-983. PubMed ID: 34689678
[TBL] [Abstract][Full Text] [Related]
20. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
Gates GA; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
